These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30862426)

  • 1. Immunotherapy in Allergic Asthma - 5 year analysis: Is it a curative approach?
    Coutinho Costa J; Machado JN; Ferreira C; Gama JMR; Almeida T; Arrobas AM
    Pulmonology; 2019; 25(3):183-185. PubMed ID: 30862426
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
    Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB
    J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rush injection therapy for asthma and allergic rhinitis.
    Greenberger PA
    Ann Allergy; 1994 Nov; 73(5):378-80. PubMed ID: 7978528
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and Safety of Subcutaneous and Sublingual Immunotherapy for Allergic Rhinoconjunctivitis and Asthma.
    Roxbury CR; Lin SY
    Otolaryngol Clin North Am; 2017 Dec; 50(6):1111-1119. PubMed ID: 28964530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-treatment by omalizumab allows allergen immunotherapy in children and young adults with severe allergic asthma.
    Lambert N; Guiddir T; Amat F; Just J
    Pediatr Allergy Immunol; 2014 Dec; 25(8):829-32. PubMed ID: 25387446
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of sublingual immunotherapy with a monomeric allergoid in very young children.
    Agostinis F; Tellarini L; Canonica GW; Falagiani P; Passalacqua G
    Allergy; 2005 Jan; 60(1):133. PubMed ID: 15575951
    [No Abstract]   [Full Text] [Related]  

  • 7. [An analysis of the subcutaneous immunotherapy on the pulmonary function and symptoms of asthma and rhinitis in children].
    Wu SJ; Chen S; Chen B; Wang L; Zeng X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 31(17):1352-1355. PubMed ID: 29798230
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of allergen immunotherapy in allergic asthma.
    Zhang W; Lin C; Sampath V; Nadeau K
    Immunotherapy; 2018 Jun; 10(7):579-593. PubMed ID: 29569506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changes in different symptom scores during subcutaneous immunotherapy in Chinese house dust mite allergic patients: a two-year, observational study.
    Tu Y; Zhang H; Zhao L; Jin P; Zi X; Li T; Shi L; Zhi L
    J Laryngol Otol; 2019 Mar; 133(3):213-219. PubMed ID: 30674357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma].
    Yepes-Núñez JJ; Gómez C; Espinoza Y; Cardona R
    Biomedica; 2014; 34(2):282-90. PubMed ID: 24967933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approach to Patients with Allergic Rhinitis: Testing and Treatment.
    Cox L
    Med Clin North Am; 2020 Jan; 104(1):77-94. PubMed ID: 31757239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis.
    Đurić-Filipović I; Caminati M; Kostić G; Filipović Đ; Živković Z
    World J Pediatr; 2016 Aug; 12(3):283-290. PubMed ID: 27351563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy in allergic rhinitis and lower airway outcomes.
    Cardona V; Luengo O; Labrador-Horrillo M
    Allergy; 2017 Jan; 72(1):35-42. PubMed ID: 27439141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides.
    Spertini F; Perrin Y; Audran R; Pellaton C; Boudousquié C; Barbier N; Thierry AC; Charlon V; Reymond C
    J Allergy Clin Immunol; 2014 Jul; 134(1):239-240.e13. PubMed ID: 24797422
    [No Abstract]   [Full Text] [Related]  

  • 15. Specific allergen immunotherapy for the treatment of allergic asthma: a review of current evidence.
    Dominguez-Ortega J; Delgado J; Blanco C; Prieto L; Arroabarren E; Cimarra M; Henriquez-Santana A; Iglesias-Souto J; Vega-Chicote JM; Tabar AI
    J Investig Allergol Clin Immunol; 2017 Jun; 27(Suppl. 1):1-35. PubMed ID: 28603089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous immunotherapy in Northern Israel: efficacy and safety.
    Rottem M; Egbarya A
    Isr Med Assoc J; 2014 Sep; 16(9):539-43. PubMed ID: 25351009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.
    Richards JR; Stumpf JL
    Ann Pharmacother; 2018 Oct; 52(10):1019-1030. PubMed ID: 29642713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SAFETY AND EFFICACY OF ONE-YEAR RUSH SUBCUTANEOUS IMMUNOTHERAPY IN JAPANESE CHILDREN, USING HOUSE DUST EXTRACT].
    Tanaka Y; Okafuji I; Narabayashi S; Tsuruta S
    Arerugi; 2015 Aug; 64(8):1160-8. PubMed ID: 26522418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does evidence support the use of cat allergen immunotherapy?
    Dhami S; Agarwal A
    Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):350-355. PubMed ID: 29870462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous immunotherapy for allergic rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases.
    Malling HJ; Bousquet J
    Clin Allergy Immunol; 2008; 21():343-58. PubMed ID: 18828516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.